A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial

• Published in: Pregnancy hypertension Vol. 18; pp. 141 - 149
• Main Authors: Pealing, Louise M., Tucker, Katherine L., Mackillop, Lucy H., Crawford, Carole, Wilson, Hannah, Nickless, Alecia, Temple, Eleanor, Chappell, Lucy C., McManus, Richard J.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.10.2019
• Subjects: Adult; Blood pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Feasibility Studies; Female; Humans; Hypertension; Maternal outcome; Perinatal outcome; Pre-Eclampsia - physiopathology; Pre-Eclampsia - prevention & control; Pregnancy; Prenatal Care; Self-monitoring; State Medicine; Telemedicine; Treatment Outcome; United Kingdom; United Kingdom; Hypertension; Pregnancy; GH; Perinatal outcome; Self-monitoring; CH; Maternal outcome; Blood pressure; SMBP
• DOI: 10.1016/j.preghy.2019.09.018
• ISSN: 2210-7789; 2210-7797

•An RCT of BP self-monitoring in hypertensive pregnancies is feasible and acceptable.•Women had high adherence and persistence with the BP self-monitoring intervention.•No difference in mean systolic BP between randomisation groups. To assess the feasibility of a blood pressure self-monitoring intervention for managing pregnancy hypertension. OPTIMUM-BP was an unmasked randomised controlled trial comparing a self-monitoring of blood pressure (SMBP) intervention versus usual care for the management of pregnancy hypertension. Women with chronic (CH) or gestational hypertension (GH) from 4 UK centres were randomised (2:1) intervention to control. Self-monitoring involved daily home blood pressure (BP) measurements, with recording via study diary or telemonitoring. Clinicians were invited to use the home readings in clinical and antihypertensive titration decisions. The primary outcomes were recruitment, retention, adherence and persistence with the intervention. Women from four UK centres were randomised: 158/222 (71%) of those approached agreed, comprising: 86 women with chronic hypertension (55 SMBP, 31 control) and 72 with gestational hypertension (49 SMBP, 23 control) of whom outcome data were available from 154 (97%) and were included in the analysis. The median (IQR) number of days with home BP readings per week were 5.5 (3.1–6.5) for those with chronic hypertension and 6.1 (4.5–6.7) with gestational hypertension. Participants persisted with the intervention for 80% or more of their time from enrolment until delivery in 86% (43/50) and 76% (38/49) of those with chronic and gestational hypertension respectively. Recorded clinic and study BPs were similar for both groups. This is the first randomised investigation of BP self-monitoring for the management of pregnancy hypertension and indicates that a large RCT would be feasible.